Nalaganje...
Infliximab in treatment of idiopathic refractory childhood pyoderma gangrenosum (PG)
We report a case of refractory idiopathic childhood pyoderma gangrenosum in a young boy who had suffered from this disease since 3 years of age. He had unfavorable responses and intermittent relapses under different combinations of cytotoxic and steroid therapies. Although there was not much informa...
Shranjeno v:
| izdano v: | Biologics |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6554516/ https://ncbi.nlm.nih.gov/pubmed/31239637 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S203753 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|